1 Min Read
March 16 (Reuters) - Oxford Biomedica Plc
* Fy EBITDA loss reduced to £7.1 million
* Fy gross income increased by 64% to £30.8 million Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.